Post by Massachusetts Institute of Technology

Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means patients have to spend hours in a hospital for every treatment. MIT engineers have now taken a major step toward reformulating antibodies so that they can be injected using a standard syringe. https://lnkd.in/e7GMwUVx